title: Letter to the editor regarding "A critical review of recombinant human morphogenetic protein-2 trials in spine surgery: emerging safety concerns and lessons learned".
authors.forename: Paul A
authors.initials: PA
authors.lastname: Anderson
mesh_terms: D055396:Bone Morphogenetic Protein 2 / Q000009:adverse effects*; D002986:Clinical Trials as Topic / Q000592:standards*; D016265:Conflict of Interest; D006801:Humans; D012107:Research Design / Q000592:standards*; D013123:Spinal Fusion / Q000379:methods*; D016212:Transforming Growth Factor beta / Q000009:adverse effects*
chemical_list: D055396:Bone Morphogenetic Protein 2; D016212:Transforming Growth Factor beta